Quarterly report · Q3
2590.TEDINET S100PQC3
Period2022-01-21 → 2022-10-20
Filed2022-12-02
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥124.6bn | 2022-01-21 → 2022-10-20 | Cons. | Net sales |
| Revenue | ¥162.6bn | 2021-01-21 → 2022-01-20 | Cons. | Net sales (5-year summary) |
| Revenue | ¥124.7bn | 2021-01-21 → 2021-10-20 | Cons. | Net sales |
| Operating income | ¥2.3bn | 2022-01-21 → 2022-10-20 | Cons. | Operating income |
| Operating income | ¥5.3bn | 2021-01-21 → 2021-10-20 | Cons. | Operating income |
| Ordinary income | ¥2.6bn | 2022-01-21 → 2022-10-20 | Cons. | Ordinary income |
| Ordinary income | ¥5.7bn | 2021-01-21 → 2022-01-20 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.0bn | 2021-01-21 → 2021-10-20 | Cons. | Ordinary income |
| Profit before tax | ¥2.9bn | 2022-01-21 → 2022-10-20 | Cons. | Income before income taxes |
| Profit before tax | ¥6.0bn | 2021-01-21 → 2021-10-20 | Cons. | Income before income taxes |
| Net income (owners) | ¥736m | 2022-01-21 → 2022-10-20 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.0bn | 2021-01-21 → 2022-01-20 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.9bn | 2021-01-21 → 2021-10-20 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥725m | 2022-01-21 → 2022-10-20 | Cons. | Profit loss |
| Net income | ¥3.9bn | 2021-01-21 → 2021-10-20 | Cons. | Profit loss |
| Total assets | ¥167.8bn | at 2022-10-20 | Cons. | Assets |
| Total assets | ¥159.0bn | at 2022-01-20 | Cons. | Assets |
| Total assets | ¥168.8bn | at 2021-10-20 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥83.7bn | at 2022-10-20 | Cons. | Liabilities |
| Total liabilities | ¥75.7bn | at 2022-01-20 | Cons. | Liabilities |
| Net assets / equity | ¥84.1bn | at 2022-10-20 | Cons. | Net assets |
| Net assets / equity | ¥83.3bn | at 2022-01-20 | Cons. | Net assets |
| Net assets / equity | ¥86.5bn | at 2021-10-20 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥28.9bn | at 2022-10-20 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.6bn | at 2022-01-20 | Cons. | Cash and deposits |
| EPS (basic) | ¥46.99 | 2022-01-21 → 2022-10-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.45 | 2022-07-21 → 2022-10-20d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥254.2 | 2021-01-21 → 2022-01-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥250.15 | 2021-01-21 → 2021-10-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥136.76 | 2021-07-21 → 2021-10-20d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 49.9% | at 2022-10-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.1% | at 2022-01-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.0% | at 2021-10-20 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-01-21 → 2022-10-20 | −¥521m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-21 → 2022-10-20 | −¥521m |
| Reconciling Itemsreconciling | segment profit | 2022-01-21 → 2022-10-20 | −¥1.0bn |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-10-20 | ¥83.6bn |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-10-20 | ¥83.5bn |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-10-20 | ¥24m |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-10-20 | ¥2.8bn |
| jpcrp040300-q3r_E00424-000Dy Do Pharmareportable segment | segment profit | 2022-01-21 → 2022-10-20 | −¥380m |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | revenue | 2022-01-21 → 2022-10-20 | ¥16.4bn |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | revenue external | 2022-01-21 → 2022-10-20 | ¥16.4bn |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-10-20 | ¥6m |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | segment profit | 2022-01-21 → 2022-10-20 | ¥1.3bn |
| jpcrp040300-q3r_E00424-000International Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-10-20 | ¥15.5bn |
| jpcrp040300-q3r_E00424-000International Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-10-20 | ¥15.5bn |
| jpcrp040300-q3r_E00424-000International Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-10-20 | −¥752m |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2022-01-21 → 2022-10-20 | ¥9.7bn |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2022-01-21 → 2022-10-20 | ¥9.2bn |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-10-20 | ¥490m |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2022-01-21 → 2022-10-20 | ¥377m |
| —segment total | revenue | 2022-01-21 → 2022-10-20 | ¥125.2bn |
| —segment total | revenue external | 2022-01-21 → 2022-10-20 | ¥124.6bn |
| —segment total | revenue intersegment | 2022-01-21 → 2022-10-20 | ¥521m |
| —segment total | segment profit | 2022-01-21 → 2022-10-20 | ¥3.3bn |
| Reconciling Itemsreconciling | revenue | 2021-01-21 → 2021-10-20 | −¥463m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-21 → 2021-10-20 | −¥463m |
| Reconciling Itemsreconciling | segment profit | 2021-01-21 → 2021-10-20 | −¥1.1bn |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2021-01-21 → 2021-10-20 | ¥89.5bn |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2021-01-21 → 2021-10-20 | ¥89.5bn |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2021-01-21 → 2021-10-20 | ¥37m |
| jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2021-01-21 → 2021-10-20 | ¥5.9bn |
| jpcrp040300-q3r_E00424-000Dy Do Pharmareportable segment | segment profit | 2021-01-21 → 2021-10-20 | −¥463m |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | revenue | 2021-01-21 → 2021-10-20 | ¥17.4bn |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | revenue external | 2021-01-21 → 2021-10-20 | ¥17.3bn |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | revenue intersegment | 2021-01-21 → 2021-10-20 | ¥15m |
| jpcrp040300-q3r_E00424-000Food Businessreportable segment | segment profit | 2021-01-21 → 2021-10-20 | ¥1.3bn |
| jpcrp040300-q3r_E00424-000International Beverage Businessreportable segment | revenue | 2021-01-21 → 2021-10-20 | ¥9.7bn |
| jpcrp040300-q3r_E00424-000International Beverage Businessreportable segment | revenue external | 2021-01-21 → 2021-10-20 | ¥9.7bn |
| jpcrp040300-q3r_E00424-000International Beverage Businessreportable segment | segment profit | 2021-01-21 → 2021-10-20 | −¥384m |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2021-01-21 → 2021-10-20 | ¥8.5bn |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2021-01-21 → 2021-10-20 | ¥8.1bn |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2021-01-21 → 2021-10-20 | ¥409m |
| jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2021-01-21 → 2021-10-20 | ¥71m |
| —segment total | revenue | 2021-01-21 → 2021-10-20 | ¥125.1bn |
| —segment total | revenue external | 2021-01-21 → 2021-10-20 | ¥124.7bn |
| —segment total | revenue intersegment | 2021-01-21 → 2021-10-20 | ¥463m |
| —segment total | segment profit | 2021-01-21 → 2021-10-20 | ¥6.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 391
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 9723000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 8532000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember | 17350000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 125121000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -463000000 | JPY |
| Net sales | Prior1YTDDuration | 124658000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 5876000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | -384000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 71000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember | 1301000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember | -463000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 6401000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -1144000000 | JPY |
| Operating income | Prior1YTDDuration | 5257000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 83529000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 15507000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 9164000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember | 16439000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 124640000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 124640000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 24000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 490000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember | 6000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 521000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -521000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 83554000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 15507000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 9654000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember | 16445000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 125161000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -521000000 | JPY |
| Net sales | CurrentYTDDuration | 124640000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 2767000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | -752000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 377000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember | 1316000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember | -380000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 3329000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -1002000000 | JPY |
| Operating income | CurrentYTDDuration | 2326000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |